関連する実験動画
Updated: Jan 6, 2026

08:53
A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
Published on: September 15, 2021
3.1K
U1 spliceosomal RNAは,複数の癌で再発的に変異している
Shimin Shuai1,2, Hiromichi Suzuki3,4, Ander Diaz-Navarro5,6
1Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Nature
|October 10, 2019
まとめ
新たに発見されたU1小核RNA (snRNA) の変異は,非コーディングがんの誘発因子として作用する. このスプライソームの変異により 新しいスプライス結合が作られ 複数の遺伝子に影響を与え 新しい治療標的となる可能性があります
科学分野:
- 腫瘍学
- ゲノミクス
- 分子生物学
背景:
- がんはゲノムの変異から生じます 主に遺伝子をコードする要因が知られているのです
- ノンコーディング・ドライバとスプレイスソーマルRNAの変異は,十分に研究されていない癌のメカニズムです.
- 異常なRNAスプライシングは癌に関与しているが,変異は主にタンパク質をコードする因子にみられる.
研究 の 目的:
- 潜在的がん誘発因子としてのスプレイスソームRNAの非コーディング変異を調査する.
- U1小核RNA (snRNA) の特定の再発性突然変異を特徴づけること.
- がんにおけるU1 snRNA変異の機能的および臨床的影響を明らかにする.
主な方法:
- 様々な腫瘍型におけるU1 snRNAの体内変異分析.
- U1 snRNA変異がRNAスプライシングに与える影響を評価するための機能研究.
- U1 snRNA変異と患者のアウトカムとリスク要因を相関させる臨床データ分析.
主要な成果:
- 繰り返し発生するA>Cの体内変異が複数の腫瘍のU1 snRNAで確認された.
- この変異は5' スプライスサイトでのU1sRNAの塩基配列を変化させ,異常なスプライスにつながります.
- この変異は,肝細胞癌と慢性リンパ球性白血病の攻撃的なサブタイプでの重度のアルコール使用と関連しており,不良の予後を与えます.
結論:
- U1 snRNAは,がんの発症に寄与する非コーディングドライバー変異を宿している.
- この発見は 癌の異常な結合の 新しいメカニズムを明らかにしています
- U1のsnRNA変異は,潜在的な新しい治療目標であり,非コーディング領域におけるより広範なドライバー発見の必要性を強調しています.
関連する概念動画
RNA Splicing
60.2K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.2K
Alternative RNA Splicing
24.6K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
24.6K
Alternative RNA Splicing
4.7K
4.7K
Non-LTR Retrotransposons
13.1K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.1K
Rous Sarcoma Virus (RSV) and Cancer
6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.1K
Cancers Originate from Somatic Mutations in a Single Cell
14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K

